<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72468</article-id><article-id pub-id-type="doi">10.7554/eLife.72468</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>NBI-921352, a first-in-class, Na<sub>V</sub>1.6 selective, sodium channel inhibitor that prevents seizures in <italic>Scn8a</italic> gain-of-function mice, and wild-type mice and rats</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-247160"><name><surname>Johnson</surname><given-names>JP</given-names><suffix>Jr</suffix></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5762-5138</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-249994"><name><surname>Focken</surname><given-names>Thilo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-249995"><name><surname>Khakh</surname><given-names>Kuldip</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-216173"><name><surname>Tari</surname><given-names>Parisa Karimi</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-249996"><name><surname>Dube</surname><given-names>Celine</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-116122"><name><surname>Goodchild</surname><given-names>Samuel J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-249997"><name><surname>Andrez</surname><given-names>Jean-Christophe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-250000"><name><surname>Bankar</surname><given-names>Girish</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-250672"><name><surname>Bogucki</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-250001"><name><surname>Burford</surname><given-names>Kristen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-250002"><name><surname>Chang</surname><given-names>Elaine</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-250855"><name><surname>Chowdhury</surname><given-names>Sultan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-250004"><name><surname>Dean</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" id="author-250005"><name><surname>de Boer</surname><given-names>Gina</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf15"/></contrib><contrib contrib-type="author" id="author-250006"><name><surname>Decker</surname><given-names>Shannon</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf16"/></contrib><contrib contrib-type="author" id="author-250007"><name><surname>Dehnhardt</surname><given-names>Christoph</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf17"/></contrib><contrib contrib-type="author" id="author-250008"><name><surname>Feng</surname><given-names>Mandy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf18"/></contrib><contrib contrib-type="author" id="author-250009"><name><surname>Gong</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf19"/></contrib><contrib contrib-type="author" id="author-250010"><name><surname>Grimwood</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf20"/></contrib><contrib contrib-type="author" id="author-250011"><name><surname>Hasan</surname><given-names>Abid</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf21"/></contrib><contrib contrib-type="author" id="author-250012"><name><surname>Hussainkhel</surname><given-names>Angela</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf22"/></contrib><contrib contrib-type="author" id="author-250013"><name><surname>Jia</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf23"/></contrib><contrib contrib-type="author" id="author-250014"><name><surname>Lee</surname><given-names>Stephanie</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf24"/></contrib><contrib contrib-type="author" id="author-250015"><name><surname>Li</surname><given-names>Jenny</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf25"/></contrib><contrib contrib-type="author" id="author-250016"><name><surname>Lin</surname><given-names>Sophia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf26"/></contrib><contrib contrib-type="author" id="author-250017"><name><surname>Lindgren</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf27"/></contrib><contrib contrib-type="author" id="author-250018"><name><surname>Lofstrand</surname><given-names>Verner</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf28"/></contrib><contrib contrib-type="author" id="author-250019"><name><surname>Mezeyova</surname><given-names>Janette</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf29"/></contrib><contrib contrib-type="author" id="author-250020"><name><surname>Namdari</surname><given-names>Rostam</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf30"/></contrib><contrib contrib-type="author" id="author-250021"><name><surname>Nelkenbrecher</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf31"/></contrib><contrib contrib-type="author" id="author-250022"><name><surname>Shuart</surname><given-names>Noah Gregory</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf32"/></contrib><contrib contrib-type="author" id="author-250023"><name><surname>Sojo</surname><given-names>Luis</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf33"/></contrib><contrib contrib-type="author" id="author-250024"><name><surname>Sun</surname><given-names>Shaoyi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf34"/></contrib><contrib contrib-type="author" id="author-250025"><name><surname>Taron</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf35"/></contrib><contrib contrib-type="author" id="author-250026"><name><surname>Waldbrook</surname><given-names>Matthew</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf36"/></contrib><contrib contrib-type="author" id="author-250027"><name><surname>Weeratunge</surname><given-names>Diana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf37"/></contrib><contrib contrib-type="author" id="author-250028"><name><surname>Wesolowski</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf38"/></contrib><contrib contrib-type="author" id="author-249999"><name><surname>Williams</surname><given-names>Aaron</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf39"/></contrib><contrib contrib-type="author" id="author-250029"><name><surname>Wilson</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf40"/></contrib><contrib contrib-type="author" id="author-250031"><name><surname>Xie</surname><given-names>Zhiwei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf41"/></contrib><contrib contrib-type="author" id="author-250030"><name><surname>Yoo</surname><given-names>Rhena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf42"/></contrib><contrib contrib-type="author" id="author-250032"><name><surname>Young</surname><given-names>Clint</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf43"/></contrib><contrib contrib-type="author" id="author-250033"><name><surname>Zenova</surname><given-names>Alla</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf44"/></contrib><contrib contrib-type="author" id="author-250034"><name><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf45"/></contrib><contrib contrib-type="author" id="author-250673"><name><surname>Cutts</surname><given-names>Alison J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4986-573X</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf46"/></contrib><contrib contrib-type="author" id="author-250037"><name><surname>Sherrington</surname><given-names>Robin P</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf47"/></contrib><contrib contrib-type="author" id="author-250038"><name><surname>Pimstone</surname><given-names>Simon N</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf48"/></contrib><contrib contrib-type="author" id="author-250039"><name><surname>Winquist</surname><given-names>Raymond</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf49"/></contrib><contrib contrib-type="author" id="author-250040"><name><surname>Cohen</surname><given-names>Charles J</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf50"/></contrib><contrib contrib-type="author" id="author-250041"><name><surname>Empfield</surname><given-names>James R</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf51"/></contrib><aff id="aff1"><institution content-type="dept">In Vitro Biology</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Chemistry</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">In Vivo Biology</institution>, <institution>University of British Columbia</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><aff id="aff4"><institution content-type="dept">In Vivo Biology</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff5"><institution content-type="dept">In Vitro Biology</institution>, <institution>Xenon Pharmaceuticals Inc</institution>, <addr-line><named-content content-type="city">Burnaby</named-content></addr-line>, <country>Canada</country></aff><aff id="aff6"><institution content-type="dept">Chemistry</institution>, <institution>Medipure Pharmaceuticals</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff7"><institution content-type="dept">Compound Properties</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff8"><institution content-type="dept">Translational Drug Development</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff9"><institution content-type="dept">Scientific Affairs</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff><aff id="aff10"><institution content-type="dept">Executive Team</institution>, <institution>Xenon Pharmaceuticals, Inc.</institution>, <addr-line><named-content content-type="city">Burnaby BC</named-content></addr-line>, <country>Canada</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-5759"><name><surname>Chanda</surname><given-names>Baron</given-names></name><role>Reviewing editor</role><aff><institution>Washington University in St. Louis</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jpjohnson@xenon-pharma.com</email> (JJ);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e72468</elocation-id><history><date date-type="received"><day>24</day><month>07</month><year>2021</year></date><date date-type="accepted"><day>23</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Johnson et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Johnson et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72468-v1.pdf"/><abstract><p>NBI-921352 (formerly XEN901) is a novel sodium channel inhibitor designed to specifically target Na<sub>V</sub>1.6 channels. Such a molecule provides a precision-medicine approach to target <italic>SCN8A</italic>-related epilepsy syndromes (<italic>SCN8A</italic>-RES), where gain-of-function (GoF) mutations lead to excess Na<sub>V</sub>1.6 sodium current, or other indications where Na<sub>V</sub>1.6 mediated hyper-excitability contributes to disease (Gardella &amp; Moller, 2019; Johannesen et al., 2019; Veeramah et al., 2012). NBI-921352 is a potent inhibitor of Na<sub>V</sub>1.6 (IC<sub>50</sub> 0.051 µM), with exquisite selectivity over other sodium channel isoforms (selectivity ratios of 756X for Na<sub>V</sub>1.1, 134X for Na<sub>V</sub>1.2, 276X for Na<sub>V</sub>1.7, and &gt;583X for Na<sub>V</sub>1.3, Na<sub>V</sub>1.4, and Na<sub>V</sub>1.5). NBI-921352 is a state-dependent inhibitor, preferentially inhibiting inactivated channels. The state dependence leads to potent stabilization of inactivation, inhibiting Na<sub>V</sub>1.6 currents, including resurgent and persistent Na<sub>V</sub>1.6 currents, while sparing the closed/rested channels. The isoform-selective profile of NBI-921352 led to a robust inhibition of action-potential firing in glutamatergic excitatory pyramidal neurons, while sparing fast-spiking inhibitory interneurons, where Na<sub>V</sub>1.1 predominates. Oral administration of NBI-921352 prevented electrically induced seizures in a <italic>Scn8a</italic> GoF mouse, as well as in wild-type mouse and rat seizure models. NBI-921352 was effective in preventing seizures at lower brain and plasma concentrations than commonly prescribed sodium channel inhibitor anti-seizure medicines (ASMs) carbamazepine, phenytoin, and lacosamide. NBI-921352 was well tolerated at higher multiples of the effective plasma and brain concentrations than those ASMs. NBI-921352 is entering phase II proof-of-concept trials for the treatment of <italic>SCN8A</italic><italic>-</italic>developmental epileptic encephalopathy (<italic>SCN8A</italic>-DEE) and adult focal-onset seizures.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Xenon Pharmaceuticals, Inc.</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Johnson</surname><given-names>JP</given-names><suffix>Jr</suffix></name><name><surname>Focken</surname><given-names>Thilo</given-names></name><name><surname>Khakh</surname><given-names>Kuldip</given-names></name><name><surname>Tari</surname><given-names>Parisa Karimi</given-names></name><name><surname>Dube</surname><given-names>Celine</given-names></name><name><surname>Goodchild</surname><given-names>Samuel J</given-names></name><name><surname>Andrez</surname><given-names>Jean-Christophe</given-names></name><name><surname>Bankar</surname><given-names>Girish</given-names></name><name><surname>Bogucki</surname><given-names>David</given-names></name><name><surname>Burford</surname><given-names>Kristen</given-names></name><name><surname>Chang</surname><given-names>Elaine</given-names></name><name><surname>Chowdhury</surname><given-names>Sultan</given-names></name><name><surname>Dean</surname><given-names>Richard</given-names></name><name><surname>de Boer</surname><given-names>Gina</given-names></name><name><surname>Decker</surname><given-names>Shannon</given-names></name><name><surname>Dehnhardt</surname><given-names>Christoph</given-names></name><name><surname>Feng</surname><given-names>Mandy</given-names></name><name><surname>Gong</surname><given-names>Wei</given-names></name><name><surname>Grimwood</surname><given-names>Michael</given-names></name><name><surname>Hasan</surname><given-names>Abid</given-names></name><name><surname>Hussainkhel</surname><given-names>Angela</given-names></name><name><surname>Jia</surname><given-names>Qi</given-names></name><name><surname>Lee</surname><given-names>Stephanie</given-names></name><name><surname>Li</surname><given-names>Jenny</given-names></name><name><surname>Lin</surname><given-names>Sophia</given-names></name><name><surname>Lindgren</surname><given-names>Andrea</given-names></name><name><surname>Lofstrand</surname><given-names>Verner</given-names></name><name><surname>Mezeyova</surname><given-names>Janette</given-names></name><name><surname>Namdari</surname><given-names>Rostam</given-names></name><name><surname>Nelkenbrecher</surname><given-names>Karen</given-names></name><name><surname>Shuart</surname><given-names>Noah Gregory</given-names></name><name><surname>Sojo</surname><given-names>Luis</given-names></name><name><surname>Sun</surname><given-names>Shaoyi</given-names></name><name><surname>Taron</surname><given-names>Matthew</given-names></name><name><surname>Waldbrook</surname><given-names>Matthew</given-names></name><name><surname>Weeratunge</surname><given-names>Diana</given-names></name><name><surname>Wesolowski</surname><given-names>Steven</given-names></name><name><surname>Williams</surname><given-names>Aaron</given-names></name><name><surname>Wilson</surname><given-names>Michael</given-names></name><name><surname>Xie</surname><given-names>Zhiwei</given-names></name><name><surname>Yoo</surname><given-names>Rhena</given-names></name><name><surname>Young</surname><given-names>Clint</given-names></name><name><surname>Zenova</surname><given-names>Alla</given-names></name><name><surname>Zhang</surname><given-names>Wei</given-names></name><name><surname>Cutts</surname><given-names>Alison J</given-names></name><name><surname>Sherrington</surname><given-names>Robin P</given-names></name><name><surname>Pimstone</surname><given-names>Simon N</given-names></name><name><surname>Winquist</surname><given-names>Raymond</given-names></name><name><surname>Cohen</surname><given-names>Charles J</given-names></name><name><surname>Empfield</surname><given-names>James R</given-names></name></principal-award-recipient></award-group><funding-statement>All of this work was funded by Xenon Pharmaceuticals, and all of the authors are, or were previously, employees of Xenon Pharmaceuticals.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>JP Johnson, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf3"><p>Thilo Focken, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf4"><p>Kuldip Khakh, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf5"><p>Parisa Karimi Tari, was previously employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf6"><p>Celine Dube, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf7"><p>Samuel J Goodchild, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf8"><p>Jean-Christophe Andrez, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf9"><p>Girish Bankar, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf10"><p>David Bogucki, was previously employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf11"><p>Kristen Burford, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf12"><p>Elaine Chang, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf13"><p>Sultan Chowdhury, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf14"><p>Richard Dean, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf15"><p>Gina de Boer, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf16"><p>Shannon Decker, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf17"><p>Christoph Dehnhardt, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf18"><p>Mandy Feng, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf19"><p>Wei Gong, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf20"><p>Michael Grimwood, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf21"><p>Abid Hasan, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf22"><p>Angela Hussainkhel, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf23"><p>Qi Jia, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf24"><p>Stephanie Lee, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf25"><p>Jenny Li, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf26"><p>Sophia Lin, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf27"><p>Andrea Lindgren, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf28"><p>Verner Lofstrand, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf29"><p>Janette Mezeyova, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf30"><p>Rostam Namdari, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf31"><p>Karen Nelkenbrecher, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf32"><p>Noah Gregory Shuart, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf33"><p>Luis Sojo, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf34"><p>Shaoyi Sun, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf35"><p>Matthew Taron, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf36"><p>Matthew Waldbrook, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf37"><p>Diana Weeratunge, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf38"><p>Steven Wesolowski, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf39"><p>Aaron Williams, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf40"><p>Michael Wilson, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf41"><p>Zhiwei Xie, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf42"><p>Rhena Yoo, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf43"><p>Clint Young, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf44"><p>Alla Zenova, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf45"><p>Wei Zhang, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf46"><p>Alison J Cutts, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf47"><p>Robin P Sherrington, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf48"><p>Simon N Pimstone, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf49"><p>Raymond Winquist, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf50"><p>Charles J Cohen, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf51"><p>James R Empfield, is employed by Xenon Pharmaceuticals, Inc. and may hold equity in Xenon Pharmaceuticals, Inc..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal research was overseen by the Xenon Animal Care Committee and the Canadian Animal Care Council (CACC) according the recommendations of the CACC (https://ccac.ca/).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All the numerical data used to generate the figures in contained in the excel data source file included in the submission.</p></sec><supplementary-material><ext-link xlink:href="elife-72468-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>